{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:12:57Z","timestamp":1759011177197,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jinf.2020.12.034","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T01:07:45Z","timestamp":1613869665000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular typing of group B Neisseria meningitidis\u2019subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period"],"prefix":"10.1016","volume":"82","author":[{"given":"Lorenzo","family":"Lodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moriondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Nieddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clementina","family":"Canessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Calistri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Citera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Resti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2020.12.034_bib0001","unstructured":"Surveillance Manual | Meningococcal | Vaccine preventable diseases | CDC [Internet]. 2020 [cited 2020 May 6]. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt08-mening.html"},{"key":"10.1016\/j.jinf.2020.12.034_bib0002","unstructured":"Meningococcal Disease | Surveillance | CDC [Internet]. [cited 2020 May 6]. Available from: https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html"},{"key":"10.1016\/j.jinf.2020.12.034_bib0003","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019. [Internet]. European Centre for Disease Prevention and Control. 2019 [cited 2020 May 6]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2017"},{"key":"10.1016\/j.jinf.2020.12.034_bib0004","unstructured":"Rapporto delle malattie batteriche invasive in Italia. Rapporto \u201cInterim\u201d 2017. Department of infectious diseases, Italian national institute of health. [Internet]. [cited 2020 May 9]. Available from: http:\/\/old.iss.it\/binary\/mabi\/cont\/InterimReport2017.pdf"},{"key":"10.1016\/j.jinf.2020.12.034_bib0005","unstructured":"Innocenti F. Epidemiologia della malattia meningococcica - epidemiological observatory ARS Toscana [Internet]. 2019 May 17 [cited 2019 May 6]. Available from: https:\/\/www.ars.toscana.it\/images\/demografia_salute\/news\/2019\/epidemiologia_malattia_meningococcica_2019.05.17_Innocenti.pdf"},{"issue":"8346","key":"10.1016\/j.jinf.2020.12.034_bib0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"10.1016\/j.jinf.2020.12.034_bib0007","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/CVI.00474-15","article-title":"Susceptibility of meningococcal strains responsible for two serogroup B outbreaks on U.S. University campuses to serum bactericidal activity elicited by the MenB-4C vaccine","volume":"22","author":"Rossi","year":"2015","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"4","key":"10.1016\/j.jinf.2020.12.034_bib0008","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.jinf.2020.12.034_bib0009","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"22","key":"10.1016\/j.jinf.2020.12.034_bib0010","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u226510 years at increased risk for serogroup B meningococcal disease: recommendations of the advisory committee on immunization practices, 2015","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.jinf.2020.12.034_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00566-16","article-title":"Recent progress in the prevention of serogroup B meningococcal disease","volume":"24","author":"Feavers","year":"2017","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"5","key":"10.1016\/j.jinf.2020.12.034_bib0012","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2020.12.034_bib0013","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/MMBR.00056-12","article-title":"Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease","volume":"77","author":"McNeil","year":"2013","journal-title":"Microbiol Mol Biol Rev MMBR"},{"issue":"39","key":"10.1016\/j.jinf.2020.12.034_bib0014","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1016\/j.vaccine.2016.08.015","article-title":"Distribution of Bexsero\u24c7 Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: implications for immunisation","volume":"34","author":"Brehony","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jinf.2020.12.034_bib0015","doi-asserted-by":"crossref","first-page":"e89921","DOI":"10.1371\/journal.pone.0089921","article-title":"Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens","volume":"9","author":"Clark","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jinf.2020.12.034_bib0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3201\/eid2203.150928","article-title":"Underestimation of invasive meningococcal disease in Italy","volume":"22","author":"Azzari","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2020.12.034_bib0017","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2018.12.061","article-title":"Genetic Meningococcal Antigen Typing System (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide","volume":"37","author":"Muzzi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2020.12.034_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02161-20","article-title":"Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) index: a rapid and accessible tool that exploits genomic data in public health and clinical microbiology applications","author":"Rodrigues","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.jinf.2020.12.034_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00207-18","article-title":"Neisseria meningitidis antimicrobial resistance in Italy, 2006 \u20132016","volume":"62","author":"Vacca","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2020.12.034_bib0020","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.vaccine.2013.09.055","article-title":"Distribution of invasive meningococcal B disease in Italian pediatric population: implications for vaccination timing","volume":"32","author":"Azzari","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2020.12.034_bib0021","unstructured":"Meningococcal Disease | 2015 Case definition | National notifiable diseases surveillance system (NNDSS) | CDC [Internet]. [cited 2020 May 6]. Available from: https:\/\/wwwn.cdc.gov\/nndss\/conditions\/meningococcal-disease\/case-definition\/2015\/"},{"issue":"3","key":"10.1016\/j.jinf.2020.12.034_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212922","article-title":"Culture and real-time polymerase chain reaction sensitivity in the diagnosis of invasive meningococcal disease: does culture miss less severe cases?","volume":"14","author":"Guiducci","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jinf.2020.12.034_bib0023","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic\u2009microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jinf.2020.12.034_bib0024","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CVI.00027-10","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine","volume":"17","author":"Lucidarme","year":"2010","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"5","key":"10.1016\/j.jinf.2020.12.034_bib0025","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2018.1450121","article-title":"Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: prevalence of strains potentially covered by the presently available meningococcal B vaccines","volume":"14","author":"Terranova","year":"2018","journal-title":"Hum Vaccines Immunother"},{"issue":"10","key":"10.1016\/j.jinf.2020.12.034_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139376","article-title":"Epidemiological and molecular characterization of invasive meningococcal disease in Italy, 2008\/09-2012\/13","volume":"10","author":"Neri","year":"2015","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jinf.2020.12.034_bib0027","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/INF.0b013e31829aa63b","article-title":"A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups","volume":"32","author":"Hoiseth","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.jinf.2020.12.034_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030469","article-title":"Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014\u20132018)","volume":"8","author":"Azzari","year":"2020","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.jinf.2020.12.034_bib0029","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2020.12.034_bib0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jinf.2020.12.034_bib0031","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jinf.2017.09.021","article-title":"Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis","volume":"75","author":"Abad","year":"2017","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jinf.2020.12.034_bib0032","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vaccines Immunother"},{"issue":"8","key":"10.1016\/j.jinf.2020.12.034_bib0033","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.vaccine.2020.01.021","article-title":"Genetic variability of polish serogroup b meningococci (2010\u20132016) including the 4CMenB vaccine component genes","volume":"38","author":"Wa\u015bko","year":"2020","journal-title":"Vaccine"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321000918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321000918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:31:14Z","timestamp":1759008674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321000918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0163445321000918"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.12.034","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular typing of group B Neisseria meningitidis\u2019subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}